UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

Gastric Tumoral Melanosis: a Rare Manifestation of Successfully Treated Malignant Melanoma

Clinical gastroenterology and hepatology, 2020-07, Vol.18 (8), p.A37-A38

2020

Volltextzugriff (PDF)

Single-Centre Experience of Systemic Treatment with Vincristine, Ifosfamide, and Doxorubicin Alternating with Etoposide, Ifosfamide, and Cisplatin in Adult Patients with Ewing Sarcoma

Sarcoma, 2017, Vol.2017, p.1781087-7

2017

Volltextzugriff (PDF)

Telomeric recombination in mismatch repair deficient human colon cancer cells after telomerase inhibition

Cancer research (Chicago, Ill.), 2004-05, Vol.64 (10), p.3444-3451

2004

Volltextzugriff (PDF)

Inter-telomeric recombination is present in telomerase-positive human cells

Cell cycle (Georgetown, Tex.), 2013-07, Vol.12 (13), p.2084-2099

2013

Volltextzugriff (PDF)

Phase I safety and pharmacokinetic dose-escalation study of pilaralisib polymorph E, a phosphoinositide 3-kinase inhibitor in tablet formulation, in patients with solid tumors or lymphoma

Cancer chemotherapy and pharmacology, 2016-07, Vol.78 (1), p.83-90

2016

Volltextzugriff (PDF)

Homologous recombination in human telomerase-positive and ALT cells occurs with the same frequency

EMBO reports, 2003-12, Vol.4 (12), p.1138-1143

2003

Volltextzugriff (PDF)

The frequency of homologous recombination in human ALT cells

Cell cycle (Georgetown, Tex.), 2004-05, Vol.3 (5), p.547-549

2004

Volltextzugriff (PDF)

Detection of circular telomeric DNA without 2D gel electrophoresis

DNA and cell biology, 2008-09, Vol.27 (9), p.489

2008

Volltextzugriff (PDF)

Vitamin D supplementation in cutaneous malignant melanoma outcome (ViDMe): a randomized controlled trial

BMC cancer, 2017-08, Vol.17 (1), p.562, Article 562

2017

Volltextzugriff (PDF)

Abstract 2993: Homologous recombination between telomeres is present in ALT and telomerase-positive immortal cells

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.2993-2993

2011

Volltextzugriff (PDF)

The Frequency of Homologous Recombination in Human ALT Cells

Cell cycle (Georgetown, Tex.), 2004-05, Vol.3 (5), p.545-547

2004

Volltextzugriff (PDF)

DNA damage repair – a new target for cancer therapy

Memo - Magazine of European medical oncology, 2009-03, Vol.2 (1), p.1-2

Bechter, Oliver E.

2009

Volltextzugriff (PDF)

Systemic therapy of soft tissue sarcomas – “nothing new under the sun?” – ASCO 2009

Memo - Magazine of European medical oncology, 2009-12, Vol.2 (4), p.208-210

Bechter, Oliver E.

2009

Volltextzugriff (PDF)

CpG island methylation of the hTERT promoter is associated with lower telomerase activity in B-cell lymphocytic leukemia

Experimental hematology, 2002, Vol.30 (1), p.26-33

2002

Volltextzugriff (PDF)

Expression of LFA-1 identifies different prognostic subgroups in patients with advanced follicle center lymphoma (FCL)

Leukemia research, 1999-05, Vol.23 (5), p.483-488

1999

Volltextzugriff (PDF)

Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study

The Lancet. Haematology, 2015-02, Vol.2 (2), p.e55-e65

2015

Volltextzugriff (PDF)

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

The Lancet (British edition), 2017-08, Vol.390 (10094), p.555-566

2017

Volltextzugriff (PDF)

Myositis as a neuromuscular complication of immune checkpoint inhibitors

Acta neurologica Belgica, 2020-04, Vol.120 (2), p.355-364

2020

Volltextzugriff (PDF)

Non-Invasive Detection of Genomic Imbalances in Hodgkin/Reed-Sternberg Cells in Early and Advanced Stage Hodgkin Lymphoma By Sequencing of Circulating Cell-Free DNA

Blood, 2014-12, Vol.124 (21), p.LBA-4-LBA-4

2014

Volltextzugriff (PDF)

Deep sequencing reveals microRNAs predictive of antiangiogenic drug response

JCI insight, 2016-07, Vol.1 (10), p.e86051-e86051

2016

Volltextzugriff (PDF)

Open-label, phase IIIb, multicenter, expanded access study of everolimus in patients with advanced neuroendocrine tumors (NET)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.4138-4138

2013

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cell Cycle
(3)
Blood
(2)
Cancer Research
(2)
Cell Cycle/cell Cycle
(2)
European Journal Of Cancer
(2)
Leukemia Research
(2)
Memo - Magazine Of European Medical Oncology
(2)
Acta Neurologica Belgica
(1)
Blood Advances
(1)
Bmc Cancer
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Gastric Tumoral Melanosis: a Rare Manifestation of Successfully Treated Malignant Melanoma

Single-Centre Experience of Systemic Treatment with Vincristine, Ifosfamide, and Doxorubicin Alternating with Etoposide, Ifosfamide, and Cisplatin in Adult Patients with Ewing Sarcoma

Telomeric recombination in mismatch repair deficient human colon cancer cells after telomerase inhibition

Inter-telomeric recombination is present in telomerase-positive human cells

Phase I safety and pharmacokinetic dose-escalation study of pilaralisib polymorph E, a phosphoinositide 3-kinase inhibitor in tablet formulation, in patients with solid tumors or lymphoma

Homologous recombination in human telomerase-positive and ALT cells occurs with the same frequency

The frequency of homologous recombination in human ALT cells

Detection of circular telomeric DNA without 2D gel electrophoresis

Vitamin D supplementation in cutaneous malignant melanoma outcome (ViDMe): a randomized controlled trial

Abstract 2993: Homologous recombination between telomeres is present in ALT and telomerase-positive immortal cells

The Frequency of Homologous Recombination in Human ALT Cells

DNA damage repair – a new target for cancer therapy

Systemic therapy of soft tissue sarcomas – “nothing new under the sun?” – ASCO 2009

CpG island methylation of the hTERT promoter is associated with lower telomerase activity in B-cell lymphocytic leukemia

Expression of LFA-1 identifies different prognostic subgroups in patients with advanced follicle center lymphoma (FCL)

Non-invasive detection of genomic imbalances in Hodgkin/Reed-Sternberg cells in early and advanced stage Hodgkin's lymphoma by sequencing of circulating cell-free DNA: a technical proof-of-principle study

Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial

Response to brentuximab vedotin versus physician’s choice by CD30 expression and large cell transformation status in patients with mycosis fungoides: An ALCANZA sub-analysis

Randomized phase 3 ALCANZA study of brentuximab vedotin vs physician's choice in cutaneous T-cell lymphoma: final data

Myositis as a neuromuscular complication of immune checkpoint inhibitors

Adjuvant therapy with pegylated interferon-alfa2b vs observation in stage II B/C patients with ulcerated primary: Results of the European Organisation for Research and Treatment of Cancer 18081 randomised trial

Superior Clinical Benefit of Brentuximab Vedotin in Mycosis Fungoides Versus Physician's Choice Irrespective of CD30 Level or Large Cell Transformation Status in the Phase 3 ALCANZA Study

Non-Invasive Detection of Genomic Imbalances in Hodgkin/Reed-Sternberg Cells in Early and Advanced Stage Hodgkin Lymphoma By Sequencing of Circulating Cell-Free DNA

Deep sequencing reveals microRNAs predictive of antiangiogenic drug response

Open-label, phase IIIb, multicenter, expanded access study of everolimus in patients with advanced neuroendocrine tumors (NET)

Suchergebnisse filtern